申请人:Eli Lilly and Company
公开号:US05229409A1
公开(公告)日:1993-07-20
The present invention involves certain 4-amino-6-substituted-tetrahydrobenz[cd]indoles and their use in treating disorders which can be benefited by modifying 5-HT A receptor function.
本发明涉及特定的4-氨基-6-取代-四氢苯并[cd]吲哚类化合物及其在治疗可以通过改变5-HT A受体功能获益的疾病中的应用。